Cardinal Health Stock Forecast
NYSE: CAHHealth CareOther PharmaceuticalsUSD
Market open · Delayed 15 min · as of Oct 9, 11:15 AM ET
CAH analyst consensus
Consensus (17 analysts)
buy
Avg. price target
$270.33+13.70%
- Strong buy 3
- Buy 11
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 17 Wall Street analysts covering Cardinal Health (2026-10-07), 14 rate the stock a buy or strong buy, 3 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $270.33, with a high estimate of $292.00 and a low estimate of $235.00. The average target implies upside of 13.7% from the current price of $237.76.
The spread between the highest and lowest targets is 24.3%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for CAH.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 18% |
| Buy | 11 | 65% |
| Hold | 3 | 18% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $235.00 | -1.16% |
| Average target | $270.33 | +13.70% |
| High target | $292.00 | +22.82% |